Infant Formula Clinical Trial
Official title:
Supplementation of Infant Formula With the Synbiotics (Lactobacillus Paracasei Ssp. Paracasei Strain F19 and Fructo- and Galactooligosaccharides).
The primary hypothesis is that Lactobacillus paracasei ssp. paracasei strain F19 in an infant formula containing FOS/GOS is safe and tolerable for use in infants from 0 to 6 months.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05578716 -
Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula
|
N/A | |
Completed |
NCT00340665 -
Study of Infant Diets on Estrogen Activity and Development
|
||
Not yet recruiting |
NCT06318117 -
Reason for Prescribing Rice Infant Formula
|
||
Completed |
NCT05224947 -
Gastric Layering and Monitoring II
|
N/A | |
Completed |
NCT05097924 -
Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns
|
||
Recruiting |
NCT05992493 -
The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants
|
||
Completed |
NCT03456934 -
Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease
|
N/A | |
Recruiting |
NCT05868408 -
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants
|
N/A | |
Completed |
NCT05295030 -
Effects of Breast Milk Simulated Infant Formula
|
N/A |